Key result
Home BP monitoring aids resistant hypertension management by excluding pseudoresistance and improving medication adherence.
Why the study?
Resistant hypertension is associated with higher mortality and morbidity, making accurate identification and effective management crucial using out-of-clinic blood pressure measurement such as home blood pressure monitoring.
Does home blood pressure monitoring improve the diagnosis and management of resistant hypertension?
Does home blood pressure monitoring improve the diagnosis and management of resistant hypertension?
Home blood pressure monitoring is a practical and effective tool for accurately diagnosing true resistant hypertension, ruling out white-coat effects, and improving patient adherence and blood pressure control.
Answers are grounded in this paper and cite their sources.
May support refined diagnosis and adherence in resistant hypertension; leaves open need for randomized outcome trials.
The definition of resistant hypertension (RHT) has been updated to include failure to achieve target blood pressure (BP) despite treatment with ≥3 antihypertensive drugs, including diuretics, renin-angiotensin system blockers, and calcium channel blockers, prescribed at the maximum or maximally tolerated doses, or as success in achieving the target blood pressure but requiring ≥4 drugs. RHT is a major clinical problem, as it is associated with higher mortality and morbidity than non-RHT. Therefore, it is crucial to accurately identify RHT patients to effectively manage their disease. Out-of-clinic BP measurement, including home BP monitoring and ambulatory BP monitoring is gaining prominence for the diagnosis and management of RHT. Home BP monitoring is advantageous as it is feasibly repetitive, inexpensive, widely available, and because of its reproducibility over long periods. In addition, home BP monitoring has crucial advantage of allowing safe titration for the maximum or maximally tolerable dose, and for self-monitoring, thereby improving clinical inertia and nonadherence, and allowing true RHT to be more accurately identified.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2023) conducted a review in Resistant hypertension. Home blood pressure monitoring vs. Ambulatory blood pressure monitoring was evaluated. Home blood pressure monitoring is a feasible, inexpensive, and reproducible tool for diagnosing and managing resistant hypertension by excluding pseudoresistance and improving medication adherence.
Synapse has enriched 10 related papers. Consider them for comparative context: